We are live on ! Find out more
BHMP

Bardin Hill Management Partners Portfolio holdings

AUM $80.3M
1-Year Est. Return 31.37%
This Fund
S&P 500
This Quarter Est. Return
+28.95%
1 Year Est. Return
+31.37%
3 Year Est. Return
+213.89%
5 Year Est. Return
+674.19%
10 Year Est. Return
+9,422.66%
AUM
$608M
AUM Growth
+$31.5M
Cap. Flow
-$50.2M
Cap. Flow %
-8.26%
Top 10 Hldgs %
69.21%
Holding
50
New
17
Increased
9
Reduced
2
Closed
17

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$27.7M
2
TSG
The Stars Group Inc.
TSG
+$23.1M
3
AGN
Allergan plc
AGN
+$17.9M
4
TIF
Tiffany & Co.
TIF
+$17.4M
5
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$17.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$59.3M
2
GWR
Genesee & Wyoming Inc.
GWR
+$42.4M
3
MDSO
Medidata Solutions, Inc.
MDSO
+$39.4M
4
PVTL
Pivotal Software, Inc.
PVTL
+$27.6M
5
VSM
Versum Materials, Inc.
VSM
+$23.5M

Sector Composition

Rank Sector Weight
1 Healthcare 22.79%
2 Energy 11.51%
3 Industrials 9.64%
4 Consumer Discretionary 8.29%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCHW
26
Charles Schwab
SCHW
$187B
$5.36M 0.88%
+112,728
New +$4.97M
FNJN
27
DELISTED
Finjan Holdings, Inc.
FNJN
$3.85M 0.63%
1,916,921
– –
GCVRZ
28
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.84M 0.47%
3,300,182
– –
TBF icon
29
ProShares Short 20+ Year Treasury ETF
TBF
$105M
$1.83M 0.3%
93,500
– –
VST.WS.A
30
DELISTED
Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024)
VST.WS.A
$392K 0.06%
180,582
– –
BMY.RT
31
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$238K 0.04%
+79,153
New +$206K
PACB icon
32
Pacific Biosciences
PACB
$363M
$126K 0.02%
+24,581
New +$125K
FIT
33
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
$25K ﹤0.01%
+6,250
New +$36.7K
HFRO
34
Highland Opportunities and Income Fund
HFRO
$406M
– –
-1,359,627
Closed -$18.2M
IHRT icon
35
iHeartMedia
IHRT
$574M
– –
-579,168
Closed -$8.69M
PCG icon
36
PG&E
PCG
$37.4B
– –
-192,496
Closed -$1.93M
CPE
37
DELISTED
Callon Petroleum Company
CPE
– –
-10
Closed –
MLNX
38
DELISTED
Mellanox Technologies, Ltd.
MLNX
– –
-39,867
Closed -$4.37M
TGE
39
PUT
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
– –
-394,040
Closed -$7.94M
GWR
40
DELISTED
Genesee & Wyoming Inc.
GWR
– –
-383,936
Closed -$42.4M
PVTL
41
DELISTED
Pivotal Software, Inc.
PVTL
– –
-1,848,288
Closed -$27.6M
PSDO
42
DELISTED
Presidio, Inc. Common Stock
PSDO
– –
-25,000
Closed -$422K
ASNA
43
DELISTED
Ascena Retail Group, Inc.
ASNA
– –
-148,630
Closed -$785K
ONCE
44
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-27,226
Closed -$2.64M
STI
45
DELISTED
SunTrust Banks, Inc.
STI
– –
-221,501
Closed -$15.2M
MDSO
46
DELISTED
Medidata Solutions, Inc.
MDSO
– –
-430,883
Closed -$39.4M
ALDR
47
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-334,479
Closed -$6.31M
VSM
48
DELISTED
Versum Materials, Inc.
VSM
– –
-444,228
Closed -$23.5M
BID
49
DELISTED
Sotheby's
BID
– –
-198,660
Closed -$11.3M
CELG
50
DELISTED
Celgene Corp
CELG
– –
-596,974
Closed -$59.3M
1
2

Similar funds

AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
BCCM
Blue Creek Capital Management Hong Kong $81.3M AUM 35.74% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.61% 1-Year Est. Return
BPC
Bryce Point Capital Scarsdale, New York $81.9M AUM 15.51% 1-Year Est. Return
KDIA
KPCB DGF II Associates Menlo Park, California $78.6M AUM 104.26% 1-Year Est. Return
LMKC
L.M. Kohn & Company Cincinnati, Ohio $83.2M AUM 19.1% 1-Year Est. Return
CM
Certares Management New York $77.3M AUM 12.22% 1-Year Est. Return

Bardin Hill Management Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Bardin Hill Management Partners held 50 positions worth $608M, up 5.5% from $577M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Bardin Hill Management Partners withdrew a net $50.2M in Q4 2019, closing 17 positions and reducing 2 holdings. Its most notable exit was Celgene Corp, an estimated $59.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 19% a quarter earlier, followed by Energy and Industrials.

Against the trend, Bardin Hill Management Partners opened a new position in Medicines Co worth $35.3M.

  • Bardin Hill Management Partners's largest Q4 2019 buy was Medicines Co: 415,862 shares worth $35.3M.
  • Bardin Hill Management Partners added most to Allergan plc in Q4 2019, an estimated $17.9M increase.
  • Bardin Hill Management Partners's biggest Q4 2019 reduction was Gen Digital, cutting an estimated $8.27M.
  • Bardin Hill Management Partners fully exited Celgene Corp in Q4 2019, selling an estimated $59.3M.
  • Bardin Hill Management Partners's ten largest holdings make up 69% of its $608M portfolio in Q4 2019.
  • Bardin Hill Management Partners opened 17 new positions and closed 17 in Q4 2019.
  • Bardin Hill Management Partners's portfolio value rose 5.5% quarter-over-quarter to $608M.

Based on Bardin Hill Management Partners's 13F filing for Q4 2019, filed 14 Feb 2020.